Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease

Marras Theodore K., Campitelli Michael A., Kwong Jeffrey C., Lu Hong, Brode Sarah K., Marchand-Austin Alex, Gershon Andrea S., Jamieson Frances B.

Source: Eur Respir J 2016; 48: 928-931
Journal Issue: September

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marras Theodore K., Campitelli Michael A., Kwong Jeffrey C., Lu Hong, Brode Sarah K., Marchand-Austin Alex, Gershon Andrea S., Jamieson Frances B.. Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease. Eur Respir J 2016; 48: 928-931

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015

Impact of pulmonary tuberculosis infection on chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Non-tuberculous mycobacterial lung disease and COPD
Source: Eur Respir Monogr 2015; 69: 172-184
Year: 2015


Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019

Chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension are the conditions predisposing to non-tuberculous mycobacterial lung disease (NTMLD)
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011


History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: 782-800
Year: 2007



Management of pulmonary nontuberculous mycobacteria disease
Source: Eur Respir Monogr 2018; 81: 222-237
Year: 2018


Non-tuberculous mycobacterial pulmonary disease
Source: Eur Respir J, 54 (1) 1900250; 10.1183/13993003.00250-2019
Year: 2019



Comorbidity: pulmonary tuberculosis and chronic obstructive pulmonary disease.
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019

Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization
Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Year: 2006


Obstructive lung disease in patients with treated pulmonary tuberculosis
Source: Annual Congress 2011 - Pulmonary and extrapulmonary tuberculosis
Year: 2011


Non tuberculous mycobacterial pulmonary disease in the elderly
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020


Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Year: 2019


Chronic obstructive pulmonary disease and nosocomial infections
Source: Eur Respir J 2005; 26: Suppl. 49, 285s
Year: 2005

Pulmonary nontuberculous mycobacerial disease in elderly patients
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019

Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013


Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 60s
Year: 2006